Showing results (1951-1960 of 3,143) with videos related to
Sort By:
Pageof 315
Arthritis and Rheumatism|November 1, 1988
Nonlinkage of the T cell receptor alpha, beta, and gamma genes to systemic lupus erythematosus in multiplex familiesD W Wong, Z Bentwich, C Martinez-Tarquino, et al.Journal of the American Academy of Child and Adolescent Psychiatry|April 7, 2019
Randomized Trial of a Computer-Assisted Intervention for Children With Autism in SchoolsMelanie Pellecchia, Steven C Marcus, Christine Spaulding, et al.Schizophrenia Bulletin|April 24, 2015
Early Childhood IQ Trajectories in Individuals Later Developing Schizophrenia and Affective Psychoses in the New England Family StudiesJessica C Agnew-Blais, Stephen L Buka, Garrett M Fitzmaurice, et al.Clinical Breast Cancer|September 1, 2006
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancerShanu Modi, Gabriella D'Andrea, Larry Norton, et al.Psychiatry Research|June 12, 2010
White matter volume abnormalities and associations with symptomatology in schizophreniaNikolaos Makris, Larry J Seidman, Todd Ahern, et al.Journal of Psychiatric Research|April 24, 2010
Revisiting the association between maternal smoking during pregnancy and ADHDSarah W Ball, Stephen E Gilman, Eric Mick, et al.Inflammatory Bowel Diseases|April 18, 2014
Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and managementRobert Battat, Uri Kopylov, Andrew Szilagyi, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinomaM Herman Chui, Yihong Wang, Ren-Chin Wu, et al.The Journal of Clinical Investigation|September 1, 1990
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomasH Zakut, G Ehrlich, A Ayalon, et al.Digestive Diseases and Sciences|December 9, 2019
Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD CenterJason Reinglas, Lorant Gonczi, Christine Verdon, et al.Pageof 315